First report 1h ago•Last update 1h ago
India Caps Mark-ups on Anti-Cancer Drugs
The Indian government has capped mark-ups on anti-cancer drugs at 30% of the Maximum Retail Price (MRP) to make them more affordable.
Background
Access to affordable healthcare, particularly life-saving medications, remains a significant challenge in India. The government has previously implemented price controls on essential medicines to address high costs and ensure wider availability for its citizens.
Quorum · collective opinions
Government Caps Mark-ups on Anti-Cancer Drugs
First report 4h agoLast update 4h ago1 takes▲ 1
positive impact on affordabilitypositiveShow 1 post
started 4h ago•Last update 4h ago
The government's decision to cap mark-ups on anti-cancer drugs is seen as a positive step towards making these crucial medications more accessible and affordable for patients.
iWitness comments
No comments yet — be the first to weigh in.